Reacting to the failure of SCoPAFF to reach a decision on renewal of the active substance glyphosate, ECPA’s Director of Public Affairs, Graeme Taylor said: “The further delay is disappointing, but we wouldn’t expect Member States to rush to a decision on such an important issue. That said 90,000 pages of evidence, 3,300 peer-reviewed studies, EFSA’s opinion, the WHO opinion of earlier this week, and a European Parliament resolution – not to mention regulatory authorities around the world – all support re-approval, yet politics is being allowed to undermine what should be a straight forward science-based approval process.”